Riley Griffiths Europe smart home healthcare market was valued at $2,785.3 million in 2020 and will grow by 27.3% annually over 2020-2030 owing to the growing healthcare expenditure, rising usage of IoT-connected smart home healthcare devices, surging prevalence of chronic diseases along with the increasing geriatric population, and growing preference for personalized healthcare.Highlighted with 32 tables and … Read more
North America smart home healthcare market is expected to grow by 25.7% annually in the forecast period and reach $40.25 billion by 2030 driven by the growing healthcare expenditure, rising usage of IoT-connected smart home healthcare devices, surging prevalence of chronic diseases along with the increasing geriatric population, and growing preference for personalized healthcare.Highlighted with … Read more
Global smart home healthcare market will reach $108.96 billion by 2030, growing by 27.4% annually over 2020-2030 driven by the growing healthcare expenditure, rising usage of IoT-connected smart home healthcare devices, surging prevalence of chronic diseases along with the increasing geriatric population, and growing preference for personalized healthcare.Highlighted with 81 tables and 73 figures, this … Read more
Asia Pacific drug discovery market will grow by 10.6% annually with a total addressable market cap of $231.8 billion over 2021-2030 owing the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents.Highlighted … Read more
Europe drug discovery market was valued at $14.8 billion in 2020 and will grow by 8.3% annually over 2020-2030 owing the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents.Highlighted with 36 … Read more
North America drug discovery market is expected to grow by 7.9% annually in the forecast period and reach $41.44 billion by 2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration … Read more
Global drug discovery market will reach $117.6 billion by 2030, growing by 8.6% annually over 2020-2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents.Highlighted with 86 tables and … Read more
Asia Pacific biosimilars market will grow by 30.7% annually with a total addressable market cap of $140.4 billion over 2021-2030 owing to the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions.Highlighted with 33 tables and 56 figures, this 116-page report … Read more
Europe biosimilars market was valued at $5,847.6 million in 2020 and will grow by 23.1% annually over 2020-2030 owing to the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions.Highlighted with 37 tables and 57 figures, this 121-page report “Europe Biosimilars … Read more
North America biosimilars market is expected to grow by 25.1% annually in the forecast period and reach $27.57 billion by 2030 driven by the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions.Highlighted with 29 tables and 54 figures, this 116-page … Read more